RXRX - Recursion Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$8.25
DETAILS
HIGH:
$11.00
LOW:
$5.50
MEDIAN:
$8.25
CONSENSUS:
$8.25
UPSIDE:
174.09%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-15 | Khan Najat | director, officer: CEO and President | F-InKind | 62,701 | $3.04 | $191K |
| 2026-05-15 | Taylor Ben R | officer: Chief Financial Officer | F-InKind | 25,018 | $3.04 | $76K |
| 2026-05-15 | Gibson Christopher | director | F-InKind | 22,821 | $3.04 | $69K |
| 2026-05-15 | Hallett David | officer: Chief Scientific Officer | F-InKind | 26,657 | $3.04 | $81K |
| 2026-05-07 | Gibson Christopher | director | C-Conversion | 60,000 | -- | -- |
| 2026-05-07 | Gibson Christopher | director | SELL | 40,000 | $3.37 | $135K |
| 2026-05-07 | Gibson Christopher | director | G-Gift | 20,000 | -- | -- |
| 2026-05-05 | Borgeson Blake | director | SELL | 30,000 | $3.52 | $106K |
| 2026-04-22 | Gibson Christopher | director | SELL | 40,000 | $3.61 | $144K |
| 2026-04-22 | Gibson Christopher | director | C-Conversion | 40,000 | -- | -- |
| 2026-04-06 | Taylor Ben R | officer: Chief Financial Officer | F-InKind | 48,028 | $3.11 | $149K |
| 2026-04-07 | Gibson Christopher | director | C-Conversion | 40,000 | -- | -- |
| 2026-04-07 | Gibson Christopher | director | SELL | 40,000 | $3.10 | $124K |
| 2026-04-07 | Borgeson Blake | director | SELL | 30,000 | $3.10 | $93K |
| 2026-04-01 | Dar Zavain | director | A-Award | 4,902 | -- | -- |
| 2026-04-01 | Li Dean Y | director | A-Award | 3,268 | -- | -- |
| 2026-03-23 | Gibson Christopher | director | C-Conversion | 40,000 | -- | -- |
| 2026-03-23 | Gibson Christopher | director | SELL | 40,000 | $3.25 | $130K |
| 2026-03-16 | Taylor Ben R | officer: Chief Financial Officer | F-InKind | 7,075 | $3.42 | $24K |
| 2026-03-17 | Taylor Ben R | officer: Chief Financial Officer | SELL | 7,956 | $3.39 | $27K |
| 2026-03-09 | Gibson Christopher | director | C-Conversion | 20,000 | -- | -- |
| 2026-03-09 | Gibson Christopher | director | G-Gift | 20,000 | -- | -- |
| 2026-03-09 | Khan Najat | director, officer: CEO and President | SELL | 28,298 | $3.35 | $95K |
| 2026-03-03 | Borgeson Blake | director | SELL | 170,000 | $3.46 | $588K |
| 2026-02-18 | Taylor Ben R | officer: Chief Financial Officer | SELL | 13,426 | $3.08 | $41K |